Share
Share
Please join us Friday, June 9, from 8:00–11:00 am for the latest from the international DOPPS Program, including our studies of in-center hemodialysis (DOPPS), peritoneal dialysis (PDOPPS), and non-dialysis advanced chronic kidney disease (CKDopps). During the program, we will present what is upcoming in the DOPPS program, and much more:
- Red blood cell transfusions across the DOPPS program
- CKDOPPS takes a deep dive into the transition to dialysis period
- Hemoglobin trajectories and outcomes in patients with CKD
- Recent changes in dialysis CKD-MBD practice patterns
- Recent PDOPPS findings in peritonitis
Session Topics
DOPPS (In-Center Hemodialysis) – 8:20 AM
Impact of etelcalcetide discontinuation on PTH levels in US hemodialysis patients (Junhui Zhao – Arbor Research)
Red blood cell transfusion rates in ND-CKD, HD, and PD (Angelo Karaboyas – Arbor Research)
Platelet count has a U-shaped association with mortality in hemodialysis patients (Xinju Zhao – Beijing, China)
PDOPPS (Peritoneal Dialysis) – 9:05 AM
Gastric acid suppression therapy and its association with peritonitis (Shira Goldman – Tel Aviv, Israel)
Burden and outcomes of pruritus in PD (Karthik Tennankore – Halifax, Canada)
International variations in serum PTH and calcium levels and their mortality associations in PD (Brian Bieber – Arbor Research)
CKDopps (Advanced CKD) – 9:50AM
Hemoglobin trajectories in nondialysis-dependent Chronic Kidney Disease and associated risk of Major Adverse Cardiovascular Events (Lisa Le Gall – Bordeaux, France)
International Variations in Vascular Access Creation and Clinical Outcomes (Murilo Guedes – Arbor Research)
Associations between functionality and clinical outcomes in ND-CKD patients (Antonio Lopes – Salvador, Brazil)
Full agenda is outlined here and in the attached PDF.
See you, Friday, June 9, from 8:00–11:00 am!
Please register before the meeting date.
If you have any questions, please contact us at the DOPPS Program Coordinating Center (DCC) at DOPPS@ArborResearch.org
December 5, 2024 — Arbor Research Collaborative for Health is proud to announce an innovative collaboration with the Nephrology Associates of Northern Illinois and Indiana (NANI), the largest private nephrology practice in the United States. This partnership marks a significant milestone in advancing chronic kidney disease (CKD) research and management by leveraging NANI’s extensive patient-level
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen
Arbor Research Collaborative for Health (Arbor Research) is proud to announce that its wholly-owned, small-business subsidiary, Arbor Research LLC, received its first competitive prime contract award. The award expands the organization’s 25-year history doing mission-impactful work in chronic disease and beyond. Arbor Research was awarded the National Cancer Institute (NCI) Center for Global Health (CGH)